Hypothesis

9 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

Homeostatic maturation programs drive human cDC2s into a tolerogenic state

1
1. scibot 19 Feb 2026
  
  in Public
  
  RRID:AB_10933429
  
  DOI: 10.1016/j.immuni.2026.01.028
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429
Visit annotations in context

Tags

RRID:AB_10933429

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761326000506
Jun 2025
52.53.155.43 52.53.155.43

1-s2.0-S2589004225009769-main-html.html

2
1. scibot 11 Jun 2025
  
  in Public
  
  RRID:AB_10933429
  
  DOI: 10.1016/j.isci.2025.112715
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429
2. scibot 11 Jun 2025
  
  in Public
  
  RRID:AB_10933429
  
  DOI: 10.1016/j.isci.2025.112715
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429
Visit annotations in context

Tags

RRID:AB_10933429

Annotators

scibot

URL

52.53.155.43/cc707e459b029b000ac6efbce15180cbbd7d6f19/PDF-html.html
Dec 2024
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer

1
1. scibot 12 Dec 2024
  
  in Public
  
  RRID:AB_10933429
  
  DOI: 10.1158/2159-8290.CD-24-0168
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429
Visit annotations in context

Tags

RRID:AB_10933429

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11609630/
Oct 2023
www.sciencedirect.com www.sciencedirect.com

Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring

1
1. scibot 27 Oct 2023
  
  in Public
  
  RRID:AB_10933429
  
  DOI: 10.1016/j.ccell.2023.09.012
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429
Visit annotations in context

Tags

RRID:AB_10933429

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610823003288
Jan 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes

1
1. scibot 25 Jan 2023
  
  in Public
  
  RRID:AB_10933429
  
  DOI: 10.1016/j.isci.2023.105929
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429
Visit annotations in context

Tags

RRID:AB_10933429

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9852696/
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Systematic analysis of CD39, CD103, CD137, and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILs

1
1. scibot 06 Jan 2023
  
  in Public
  
  RRID:AB_10933429
  
  DOI: 10.1002/eji.202149329
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429
Visit annotations in context

Tags

RRID:AB_10933429

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8755575/
Nov 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies

1
1. scibot 05 Nov 2021
  
  in Public
  
  AB_10933429
  
  DOI: 10.1158/2159-8290.CD-20-1243
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429
Visit annotations in context

Tags

RRID:AB_10933429

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8406797/
Jan 2020
www.cell.com www.cell.com

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:AB_10933429
  
  DOI: 10.1016/j.celrep.2019.04.091
  
  Resource: (BioLegend Cat# 329922, RRID:AB_10933429)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:AB_10933429
  
  What is this?
  
  RRID:AB_10933429 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:AB_10933429

RRIDCUR:Validated

Annotators

scibot

URL

cell.com/cell-reports/fulltext/S2211-1247(19)30571-6